Read + Share
Amedeo Smart
Independent Medical Education
Wang M, Jing X, Chen F, Lu S, et al. Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior immunotherapy in patients with driver-gene negative advanced non-small cell lung cancer. BMC Cancer 2024;24:569.PMID: 38714983
Email
LinkedIn
Privacy Policy